ANKRD44 Gene Silencing: A Putative Role in Trastuzumab Resistance in Her2-Like Breast Cancer

Trastuzumab is an effective therapeutic treatment for Her2-like breast cancer; despite this most of these tumors develop resistance to therapy due to specific gene mutations or alterations in gene expression. Understanding the mechanisms of resistance to Trastuzumab could be a useful tool in order t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Oncol
Main Authors: La Ferla, Marco, Lessi, Francesca, Aretini, Paolo, Pellegrini, Davide, Franceschi, Sara, Tantillo, Elena, Menicagli, Michele, Marchetti, Ivo, Scopelliti, Claudia, Civita, Prospero, De Angelis, Claudia, Diodati, Lucrezia, Bertolini, Ilaria, Roncella, Manuela, McDonnell, Liam A., Hochman, Jacob, Del Re, Marzia, Scatena, Cristian, Naccarato, Antonio G., Fontana, Andrea, Mazzanti, Chiara M.
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6607964/
https://ncbi.nlm.nih.gov/pubmed/31297336
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2019.00547
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados